News blog

Neurologist charged with insider trading

The phone calls began in 2007, if not earlier. After safety committee meetings regarding clinical trials of an experimental Alzheimer’s drug, neurologist  and committee-chairman Sidney Gilman would ring Mathew Martoma, a hedge-fund manager for CR Intrinsic Investors, based in Stamford, Connecticut, to fill him in on the latest data 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE